Sylvain Lamoine

发表

Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives

N. Kerckhove, J. Busserolles, D. Balayssac, 2015, Expert opinion on drug safety.

Centrally expressed Cav3.2 T-type calcium channel is critical for the initiation and maintenance of neuropathic pain

B. Cauli, S. Laffray, N. Leresche, 2022, bioRxiv.

Targeting the TREK-1 potassium channel via riluzole to eliminate the neuropathic and depressive-like effects of oxaliplatin

D. A. Barrière, A. Eschalier, M. Lazdunski, 2018, Neuropharmacology.

Neuropathic pain-alleviating activity of novel 5-HT6 receptor inverse agonists derived from 2-aryl-1H-pyrrole-3-carboxamide.

A. Eschalier, M. Pawłowski, A. Bojarski, 2021, Bioorganic chemistry.

Design, synthesis and biological evaluation of conformationnally-restricted analogues of E7010 as inhibitors of tubulin assembly (ITA) and vascular disrupting agents (VDA).

F. De Ceuninck, S. Ducki, C. Mallet, 2022, European journal of medicinal chemistry.

The Class I HDAC Inhibitor, MS-275, Prevents Oxaliplatin-Induced Chronic Neuropathy and Potentiates Its Antiproliferative Activity in Mice

D. A. Barrière, A. Eschalier, J. Busserolles, 2021, International journal of molecular sciences.

Epigenetics Involvement in Oxaliplatin-Induced Potassium Channel Transcriptional Downregulation and Hypersensitivity

A. Eschalier, J. Busserolles, D. Balayssac, 2021, Molecular Neurobiology.

The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice

A. Eschalier, Y. Jacquot, C. Mallet, 2021, Frontiers in Endocrinology.

The Constitutive Activity of Spinal 5-HT6 Receptors Contributes to Diabetic Neuropathic Pain in Rats

P. Marin, Y. Aissouni, F. Lamaty, 2023, Biomolecules.

The TREK-1 potassium channel is involved in both the analgesic and anti-proliferative effects of riluzole in bone cancer pain.

M. Meleine, J. Busserolles, Y. Aissouni, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.